NanoVibronix, Inc. (NAOV) Financial Statements (2025 and earlier)
Company Profile
Business Address |
969 PRUITT AVE, TYLER, TX 77569 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 3,283 | 2,713 | 7,737 | 7,142 | 1,338 | 896 | |||
Cash and cash equivalent | 3,283 | 2,713 | 7,737 | 7,142 | 1,338 | 896 | |||
Restricted cash and investments | 391 | ||||||||
Receivables | 318 | 9 | 200 | 25 | 111 | 144 | |||
Inventory, net of allowances, customer advances and progress billings | 2,732 | 2,175 | 175 | 145 | 121 | 144 | |||
Inventory | 2,732 | 2,175 | 175 | 145 | 121 | 144 | |||
Prepaid expense | 47,000 | 612 | 166 | 199 | 249 | 42 | |||
Other current assets | 107,000 | 100 | 64 | 68 | 19 | ||||
Other undisclosed current assets | (153,846) | 4 | |||||||
Total current assets: | 6,487 | 5,609 | 8,342 | 7,970 | 1,838 | 1,230 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 5 | 81 | 49 | 31 | ✕ | ||||
Property, plant and equipment | 7 | 7 | 5 | 4 | 4 | 8 | |||
Other noncurrent assets | 1 | 3 | 19 | 25 | |||||
Other undisclosed noncurrent assets | 174 | 179 | 207 | 199 | 194 | 346 | |||
Total noncurrent assets: | 187 | 270 | 280 | 259 | 198 | 354 | |||
Other undisclosed assets | (4) | ||||||||
TOTAL ASSETS: | 6,674 | 5,879 | 8,622 | 8,229 | 2,036 | 1,580 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 138 | 66 | 87 | 144 | 129 | ||||
Accounts payable | 138 | 66 | 87 | 144 | 129 | ||||
Deferred revenue | ✕ | ||||||||
Other undisclosed current liabilities | 2,316 | 2,250 | 1,816 | 2,758 | 280 | 640 | |||
Total current liabilities: | 2,454 | 2,316 | 1,903 | 2,902 | 409 | 640 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 18 | ||||||||
Liabilities, other than long-term debt | 232 | 330 | 406 | 2,915 | 279 | 477 | |||
Accounts payable and accrued liabilities | 217 | 223 | 253 | 245 | 279 | 477 | |||
Deferred revenue | 15 | 107 | 153 | 199 | ✕ | ||||
Operating lease, liability | 18 | ✕ | |||||||
Derivative instruments and hedges, liabilities | 2,471 | ||||||||
Other undisclosed noncurrent liabilities | 640 | ||||||||
Total noncurrent liabilities: | 232 | 330 | 406 | 2,933 | 279 | 1,117 | |||
Other undisclosed liabilities | (640) | ||||||||
Total liabilities: | 2,686 | 2,646 | 2,309 | 5,835 | 688 | 1,117 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 3,988 | 3,233 | 6,313 | 2,394 | 1,348 | 463 | |||
Common stock | 2 | 2 | 28 | 22 | 5 | 4 | |||
Additional paid in capital | 70,149 | 65,634 | 63,162 | 44,959 | 39,669 | 32,993 | |||
Accumulated other comprehensive income (loss) | (67) | (18) | 60 | 66 | |||||
Accumulated deficit | (66,096) | (62,385) | (56,937) | (42,655) | (38,330) | (32,563) | |||
Other undisclosed equity, attributable to parent | 2 | 4 | 29 | ||||||
Total equity: | 3,988 | 3,233 | 6,313 | 2,394 | 1,348 | 463 | |||
TOTAL LIABILITIES AND EQUITY: | 6,674 | 5,879 | 8,622 | 8,229 | 2,036 | 1,580 |
Income Statement (P&L) ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 2,283 | 752 | 1,695 | 623 | 530 | 318 | ||
Cost of revenue | (746) | (585) | (925) | (409) | (249) | (158) | ||
Gross profit: | 1,537 | 167 | 770 | 214 | 281 | 160 | ||
Operating expenses | (4,973) | (5,179) | (6,453) | (4,933) | (5,432) | (4,463) | ||
Operating loss: | (3,436) | (5,012) | (5,683) | (4,719) | (5,151) | (4,303) | ||
Nonoperating income (expense) | 102 | (22) | ||||||
Investment income, nonoperating | 102 | |||||||
Other nonoperating expense | (22) | |||||||
Interest and debt expense | (135) | (347) | (147) | (303) | ||||
Loss from continuing operations before equity method investments, income taxes: | (3,571) | (5,359) | (5,683) | (4,866) | (5,352) | (4,325) | ||
Other undisclosed income (loss) from continuing operations before income taxes | (111) | (54) | (8,567) | 555 | (459) | 44 | ||
Loss from continuing operations before income taxes: | (3,682) | (5,413) | (14,250) | (4,311) | (5,811) | (4,281) | ||
Income tax expense (benefit) | (29) | (35) | (32) | (15) | 17 | 127 | ||
Loss from continuing operations: | (3,711) | (5,448) | (14,282) | (4,326) | (5,794) | (4,154) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (14,282) | (4,326) | (5,794) | (4,154) | |
Net loss: | (3,711) | (5,448) | (14,282) | (4,326) | (5,794) | (4,154) | ||
Other undisclosed net income attributable to parent | 1 | |||||||
Net loss attributable to parent: | (3,711) | (5,448) | (14,282) | (4,325) | (5,794) | (4,154) | ||
Other undisclosed net income (loss) available to common stockholders, basic | (6) | 66 | ||||||
Net loss available to common stockholders, diluted: | (3,711) | (5,448) | (14,288) | (4,259) | (5,794) | (4,154) |
Comprehensive Income ($ in thousands)
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (3,711) | (5,448) | (14,282) | (4,326) | (5,794) | (4,154) | ||
Other comprehensive income (loss) | (49) | (78) | (6) | 66 | ||||
Comprehensive loss: | (3,760) | (5,526) | (14,288) | (4,260) | (5,794) | (4,154) | ||
Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
Comprehensive loss, net of tax, attributable to parent: | (3,760) | (5,526) | (14,288) | (4,260) | (5,794) | (4,154) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.